In a release issued under the same headline earlier today by Waldencast plc (NASDAQ: WALD), please note that the quote by Michael Pennington in ...
The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application for a registrational phase 3 clinical trial of iSCIB1+ for patients with advanced melanoma, a step that ...
Shell Canada Limited (Shell), a subsidiary of Shell plc, is joining the Scene+ loyalty partner network – teaming up with Scene+, Scotiabank and Tangerine to unlock new ways for eligible members to ...
Zacks Investment Research on MSN
BAE Systems wins $473M deal to produce 40 M109A7 Paladin howitzer
BAE Systems plc BAESY recently stated that it has clinched a $473 million deal for the production of 40 additional M109A7 Paladin Self-Propelled Howitzer sets, which includes the M992A3 Carrier ...
Opportunities in the Global MBA Education Market are driven by flexible delivery models and technical skill integration like ...
Unlocks path towards registrational Phase 3 trial planned to start in 2026 Data from Phase 2 SCOPE trial show iSCIB1+ has potential to redefine standard of care (SoC) iSCIB1+ shows an interim 24%-poin ...
Unlocks path towards registrational Phase 3 trial planned to start in 2026 Data from Phase 2 SCOPE trial show iSCIB1+ has potential to redefine standard of care (SoC) iSCIB1+ shows an interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results